Peptide drug conjugate development
Cybrexa develops antigen-independent peptide drug conjugates aimed at ovarian, breast and non-small cell lung cancers, among other cancer types.
Source: LinkedIn company description · Retrieved October 13, 2026
Company profilecybrexa.com ↗
Cybrexa Therapeutics
Cybrexa is a clinical-stage oncology biotechnology company developing antigen-independent peptide drug conjugates aimed at several cancer types.
- Headquarters
- New Haven, Connecticut, United StatesSource: RevenueBaseRetrieved October 13, 2026
- Employee range
- 11 to 50Source: RevenueBaseRetrieved October 13, 2026
- Founded
- 2017Source: RevenueBaseRetrieved October 13, 2026
- Published list appearances
- 2 supported appearances ↗Source: RevenueBase lists
What does Cybrexa Therapeutics do?
Cybrexa’s alphalex technology is an antigen-independent peptide drug conjugate platform. The company reports efficacy signals and tolerability for its lead candidate CBX-12 in early clinical trials involving patients with metastatic cancer.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Services & capabilities.
Company lists.
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
#19OF 25
↗#22OF 25
↗Positions describe ordering within each source list. See how lists are built ↗
Share your recognition
Embeddable award for your website
BADGE PREVIEW
Open the published source list.
Open the published source list.Company information
Sources & data notes.
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 19, 2026. How the company lists are built.
Help keep this profile accurate
Something changed?
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Find your next account
Explore company profiles →One company is just the start.
Explore more companies by name, headquarters and business focus.